Patients with severe gag reflex (SGR) have difficulty getting the treatment they require in local clinics, and many tend to postpone the start of their treatment. To address this problem, dentists have used behavioral techniques and/or pharmacological techniques for treatment. Among the pharmacological methods available, propofol IV sedation is preferred over general anesthesia because it is a simpler procedure. Propofol in combination with remifentanil is characterized by stable sedative effects and quick recovery, leading to a deep sedation. Remifentanil acts to reduce the pain caused by lipid-soluble propofol on injection. The synergistic effects of propofol-remifentanil include reduction in the total amount of drug required to achieve a desired sedation level and anti-emetic effects. In this case report, we outline how the use of propofol-remifentanil IV sedation enabled us to successfully complete a wide range of dental treatments in a patient with SGR.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Gag reflex (GR) is described as a normal defense mechanism that prevents foreign bodies from entering the trachea, pharynx, or larynx. However, some patients have a severe gag reflex that makes it difficult for them to receive dental treatment, and they may consequently miss or postpone treatment.
The etiology of GR is categorized as either somatic or psychologic. Somatic responses occur in response to physical stimuli in the posterior palate, base of tongue or throat, while psychologic responses are induced by fear or horror [1] . A psychological GR can be also triggered by fear and anxiety associated with previous dental care, in the absence of physical stimuli.
Research has continued to manage GR in patients with SGR by applying behavioral techniques and pharmacological techniques. At the same time, the IV sedation method, which is commonly used to relieve gagging and fear during gastrointestinal endoscope examination, has been introduced and widely used for dental treatment [2] .
In this case report, we present a case of effective use of propofol-remifentanil IV sedation for dental treatment on a patient with SGR.
CASE REPORT
A 41-year-old male patient (60 kg, 170 cm) without significant medical history was admitted to our hospital for restorative and prosthetic treatment. During his visit, consent for release of information was obtained. It was found that he suffered from SGR and postponed dental treatment for a long time due to his fear and anxiety about The patient had undergone treatment in local clinics using various behavioral and pharmacological techniques, but could not continue treatment due to severe gagging.
He visited our hospital after discovering the availability of sedation-based care. After admission, he showed considerable fear and anxiety during routine oral examinations, and had GR when the dental mirror was placed inside his mouth, forcing us to examine his anterior teeth, and take a panoramic radiograph only. The patient requested IV sedation to have a periapical radiograph taken, and his posterior teeth examined. After consultation with the patient, we decided to both treat his anterior teeth, and examine his posterior teeth under the 1st sedation.
On the appointment date, the patient returned to the hospital after an 8-hour fast. After a systemic examination, sedation was administered. Supplemental oxygen at 2 L/min was supplied via a nasal cannula, and the IV line established using conventional venipuncture for propofol-remifentanil administration (Fig 1) . A target controlled infusion (TCI) device (Orchestra Infusion Workstation, Fresenius Vial, Brezins, France) was used to set and administer remifentanil at a target plasma concentration of 1.0 ng/ml, which was then followed by the infusion of propofol at a target plasma concentration of 1.3 μg/ml under neuroleptanalgesia (Fig 2) . After administration, upon the observation of ptosis, we began the oral examination. immediately left the dental chair to go to the recovery room. At the time of discharge, consciousness was fully regained, and he left after 20-30 minutes with his caregiver.
The patient has subsequently undergone IV sedation six times. The procedures and dental treatment, sedation and operation time, and dose of drugs administered are detailed in Table 1 . Routes of sedation include oral, inhalation, and intravenous injection. Oral sedation is characterized by different times for onset of action and low sedation success, while inhalation sedation is characterized by low sedative and analgesic effects, low potency, and ineffectiveness.
DISCUSSION
In contrast, IV sedation delivers quick onset time of sedation and allows control of sedative effects, rapid recovery, and safety.
Propofol is highly lipid-soluble and provides quick redistribution, rapid onset of action, short duration of effect, and rapid recovery with minimal postanesthetic side effects, making it popular for IV sedation [6] . In addition, low incidences of nausea or vomiting postanesthesia enable early discharge and, when an appropriate dose is used, anxiolytic effects like midazolam and amnesiatic effects are observed [7] . However, propofol causes a 30% drop in arterial blood pressure due to decreases in peripheral vascular resistance and myocardial contractility. This result can be partly avoided by reducing the rate of drug ingestion. Therefore, propofol must not be used for hypovolemic patients. Propofol can This case report describes a patient with SGR admitted to our hospital after failing to get treatment from local clinics. We could complete various dental procedures successfully without triggering SGR. Unlike general anesthesia, conscious sedation maintains consciousness during the treatment process, making it easy to monitor patient symptoms and signs, and is useful for procedures where patient cooperation is needed. Since then, general treatment that could be performed without stimulating the intraoral region was provided in an outpatient setting, as patient sensitivity to GR decreased with increasing familiarity with the dental environment and relaxation [12] . This case confirms that patients with SGR can receive almost all dental treatments under IV sedation.
It is also likely that effective behavioral outcomes, and desensitization of the intraoral region, help increase the threshold of gag reflex.
In approximately 60 cases treated over the last 4 years, there has been no situation in which severe gag reflex was not controlled and treatment had to be discontinued.
In conclusion, we report that propofol-remifentanil IV sedation is an effective method for reducing SGR, and enables almost all dental treatments to be completed successfully, along with positive effects on behavior management.
NOTES:
There are no financial or other issues that might lead to conflict of interest.
